Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
94.941,34
0,84%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CTI BioPharma Corporation (CTIC) CTI BioPharma Corporation (CTIC) Notizie

CTIC

CTI BioPharma (CTIC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CTIC
DataOraFonteTitoloSimboloCompagnia
06/07/202322:15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CTICCTI BioPharma Corporation
30/06/202312:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CTICCTI BioPharma Corporation
30/06/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CTICCTI BioPharma Corporation
29/06/202300:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTICCTI BioPharma Corporation
29/06/202300:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTICCTI BioPharma Corporation
28/06/202319:51Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CTICCTI BioPharma Corporation
26/06/202323:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CTICCTI BioPharma Corporation
26/06/202322:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CTICCTI BioPharma Corporation
26/06/202316:35Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CTICCTI BioPharma Corporation
26/06/202315:21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CTICCTI BioPharma Corporation
26/06/202314:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTICCTI BioPharma Corporation
26/06/202312:08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CTICCTI BioPharma Corporation
24/06/202312:51PR Newswire (US)Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.NASDAQ:CTICCTI BioPharma Corporation
30/05/202322:35PR Newswire (US)CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of StockholdersNASDAQ:CTICCTI BioPharma Corporation
25/05/202313:01Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CTICCTI BioPharma Corporation
25/05/202312:46Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CTICCTI BioPharma Corporation
15/05/202322:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTICCTI BioPharma Corporation
10/05/202320:03Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CTICCTI BioPharma Corporation
10/05/202307:06PR Newswire (US)Sobi to Acquire CTI BioPharmaNASDAQ:CTICCTI BioPharma Corporation
05/05/202301:55PR Newswire (US)CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CTICCTI BioPharma Corporation
01/05/202322:46PR Newswire (US)CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023NASDAQ:CTICCTI BioPharma Corporation
01/05/202313:03PR Newswire (US)CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CTICCTI BioPharma Corporation
28/04/202322:14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CTICCTI BioPharma Corporation
28/04/202322:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTICCTI BioPharma Corporation
14/04/202314:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTICCTI BioPharma Corporation
12/04/202322:30PR Newswire (US)CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023NASDAQ:CTICCTI BioPharma Corporation
06/03/202322:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTICCTI BioPharma Corporation
06/03/202312:25PR Newswire (US)CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:CTICCTI BioPharma Corporation
01/03/202322:20PR Newswire (US)CTI BioPharma to Present at the 43rd Annual Cowen Health Care ConferenceNASDAQ:CTICCTI BioPharma Corporation
23/02/202313:03PR Newswire (US)CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023NASDAQ:CTICCTI BioPharma Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CTIC

La tua Cronologia

TSXV
MIR
MedMira
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network